Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Beta-Blockers Emerge as Beneficial in Early and Triple-Negative Breast Cancer: Reasons Why and the Role of a Sympathetic Overdrive in TNBC Patients
Timing is everything: Novel Combinatorial Approaches to Overcome the Immunosuppression in Prostate Cancer
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Platelet-activating anti-PF4 antibodies linked to the vaccine-induced immune thrombotic thrombocytopeniaApril 19, 2021
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe CasesFebruary 6, 2021
NIH begins the first large randomized controlled trial of the combination of interferon beta-1a and remdesivir for treating COVID-19August 13, 2020
The Top 10 BrainImmune Updates and Why These Stories Are Fundamentally and Clinically ImportantDecember 8, 2022
Encouraging Results from Phase 2a COVID-19 Clinical Trial with the Oral Direct-Acting Antiviral MolnupiravirJuly 7, 2021
Bamlanivimab (an Investigational Monoclonal Antibody): FDA Authorizes its Emergency Use for the Treatment of Mild to Moderate COVID-19November 11, 2020
